These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12088587)

  • 1. Vaccination against meningococcal disease: which vaccine to use?
    Bröker M
    J Travel Med; 2002; 9(3):168-9. PubMed ID: 12088587
    [No Abstract]   [Full Text] [Related]  

  • 2. Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease.
    Pollard AJ; Green C; Sadarangani M; Snape MD
    Arch Dis Child; 2013 Apr; 98(4):248-51. PubMed ID: 23482919
    [No Abstract]   [Full Text] [Related]  

  • 3. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
    [No Abstract]   [Full Text] [Related]  

  • 4. An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine.
    Keshavan P; Pellegrini M; Vadivelu-Pechai K; Nissen M
    Expert Rev Vaccines; 2018 Oct; 17(10):865-880. PubMed ID: 30198805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early estimate of the effectiveness of quadrivalent meningococcal conjugate vaccine.
    Macneil JR; Cohn AC; Zell ER; Schmink S; Miller E; Clark T; Messonnier NE;
    Pediatr Infect Dis J; 2011 Jun; 30(6):451-5. PubMed ID: 21206392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningococcal C conjugate vaccination recommendations for infants. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Nov; 33(ACS-11):1-12. PubMed ID: 18064747
    [No Abstract]   [Full Text] [Related]  

  • 7. [Meningococcal vaccine. Editorial].
    Gendrel D; Cohen R
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S47-8. PubMed ID: 22883365
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom.
    Auckland C; Gray S; Borrow R; Andrews N; Goldblatt D; Ramsay M; Miller E
    J Infect Dis; 2006 Dec; 194(12):1745-52. PubMed ID: 17109348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges for development of meningococcal vaccines in infants and children.
    Deasy A; Read RC
    Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MenACWY-TT vaccine for active immunization against invasive meningococcal disease.
    Papaevangelou V; Spyridis N
    Expert Rev Vaccines; 2012 May; 11(5):523-37. PubMed ID: 22827239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.
    Caro JJ; Möller J; Getsios D; Coudeville L; El-Hadi W; Chevat C; Nguyen VH; Caro I
    BMC Public Health; 2007 Jun; 7():130. PubMed ID: 17603880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose escalation, safety and immunogenicity study of a tetravalent meninogococcal polysaccharide diphtheria conjugate vaccine in toddlers.
    Rennels M; King J; Ryall R; Manoff S; Papa T; Weddle A; Froeschle J
    Pediatr Infect Dis J; 2002 Oct; 21(10):978-9. PubMed ID: 12400528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group C meningococcal vaccine trial: safety, immunogenicity and parents' views of participation.
    Jonas C
    Paediatr Nurs; 2001 Feb; 13(1):23-6. PubMed ID: 12024434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Boccalini S; Panatto D; Mennini FS; Marcellusi A; Bini C; Amicizia D; Lai PL; Micale RT; Frumento D; Azzari C; Ricci S; Bonito B; DI Pisa G; Iovine M; Lodi L; Giovannini M; Moscadelli A; Paoli S; Pennati BM; Pisano L; Bechini A; Bonanni P
    J Prev Med Hyg; 2021 Mar; 62(1 Suppl 1):E1-E128. PubMed ID: 34622076
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Cohn AC; MacNeil JR; Clark TA; Ortega-Sanchez IR; Briere EZ; Meissner HC; Baker CJ; Messonnier NE;
    MMWR Recomm Rep; 2013 Mar; 62(RR-2):1-28. PubMed ID: 23515099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal vaccine for infants?
    Campos-Outcalt D
    J Fam Pract; 2012 Aug; 61(8):482-4. PubMed ID: 22871657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal vaccine for adolescents and college freshmen.
    FDA Consum; 2005; 39(5):4. PubMed ID: 16421984
    [No Abstract]   [Full Text] [Related]  

  • 18. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis.
    Ramsay ME; Andrews NJ; Trotter CL; Kaczmarski EB; Miller E
    BMJ; 2003 Feb; 326(7385):365-6. PubMed ID: 12586669
    [No Abstract]   [Full Text] [Related]  

  • 19. Meningococcal Disease: Vaccines-Who's at Risk and the Future.
    O'Malley PA
    Clin Nurse Spec; 2018; 32(1):15-18. PubMed ID: 29200035
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-meningococcal vaccines: diversity of vaccination policies and recommendations].
    Gendrel D
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S70-6. PubMed ID: 22883370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.